Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review
Open Access
- 1 January 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 16 (1), R7
- https://doi.org/10.1186/cc11145
Abstract
A strong biologic rationale exists for targeting markers of endothelial cell (EC) activation as clinically informative biomarkers to improve diagnosis, prognostic evaluation or risk-stratification of patients with sepsis. The objective was to review the literature on the use of markers of EC activation as prognostic biomarkers in sepsis. MEDLINE was searched for publications using the keyword 'sepsis' and any of the identified endothelial-derived biomarkers in any searchable field. All clinical studies evaluating markers reflecting activation of ECs were included. Studies evaluating other exogenous mediators of EC dysfunction and studies of patients with malaria and febrile neutropenia were excluded. Sixty-one studies were identified that fulfilled the inclusion criteria. Overall, published studies report positive correlations between multiple EC-derived molecules and the diagnosis of sepsis, supporting the critical role of EC activation in sepsis. Multiple studies also reported positive associations for mortality and severity of illness, although these results were less consistent than for the presence of sepsis. Very few studies, however, reported thresholds or receiver operating characteristics that would establish these molecules as clinically-relevant biomarkers in sepsis. Multiple endothelial-derived molecules are positively correlated with the presence of sepsis in humans, and variably correlated to other clinically-important outcomes. The clinical utility of these biomarkers is limited by a lack of assay standardization, unknown receiver operating characteristics and lack of validation. Additional large-scale prospective clinical trials will be required to determine the clinical utility of biomarkers of endothelial activation in the management of patients with sepsis.Keywords
This publication has 105 references indexed in Scilit:
- Endothelial Cell Activation in Emergency Department Patients with Sepsis-Related and Non-Sepsis-Related HypotensionShock, 2011
- The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsisCritical Care, 2010
- Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivityCritical Care, 2010
- Sepsis biomarkers: a reviewCritical Care, 2010
- Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunctionCritical Care, 2009
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Circulating Precursor Levels of Endothelin-1 and Adrenomedullin, Two Endothelium-Derived, Counteracting Substances, in SepsisEndothelium, 2007
- Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortalityThe Journal of Experimental Medicine, 2006
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- APACHE IICritical Care Medicine, 1985